[Federal Register: March 18, 2003 (Volume 68, Number 52)] [Notices] [Page 12911-12912] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr18mr03-59] ======================================================================= ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Advisory Committee; Renewals AGENCY: Food and Drug Administration, HHS. ACTION: Notice. ----------------------------------------------------------------------- SUMMARY: The Food and Drug Administration (FDA) is announcing the renewal of certain FDA advisory committees by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the charters of the committees listed in the following table for an additional 2 years beyond charter expiration date. The new charters will be in effect until the dates of expiration listed in the following table. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Public Law 92- 463 (5 U.S.C. app. 2)). DATES: Authority for these committees will expire on the dates indicated in the following table unless the Commissioner formally determines that renewal is in the public interest. ------------------------------------------------------------------------ Name of committee Date of expiration ------------------------------------------------------------------------ Science Board to the Food and Drug June 26, 2004 Administration Allergenic Products Advisory July 9, 2004 Committee Cardiovascular Drugs Advisory August 27, 2004 Committee Endocrinologic and Metabolic Drugs August 27, 2004 Advisory Committee Oncologic Drugs Advisory Committee September 1, 2004 Anti-Infective Drugs Advisory October 7, 2004 Committee Dermatologic and Ophthalmic Drugs October 7, 2004 Advisory Committee Biological Response Modifiers October 28, 2004 Advisory Committee Technical Electronic Product December 24, 2004 Radiation Safety Standards Committee Antiviral Drugs Advisory Committee February 15, 2005 ------------------------------------------------------------------------ [[Page 12912]] FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee Oversight and Management Staff (HF-4), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1220. Dated: March 10, 2003. Linda Arey Skladany, Associate Commissioner for External Relations. [FR Doc. 03-6397 Filed 3-17-03; 8:45 am] BILLING CODE 4160-01-S